Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Phosphate Binders
DRUG
2 trials
Sponsors
Eli Lilly and Company
, Mansoura University
Conditions
Advanced Cancer
CKD 5D, Hemodialysis
CKD-MBD - Chronic Kidney Disease Mineral and Bone Disorder
End Stage Renal Disease (ESRD)
Phase 1
A Phase 1 Study of LY2874455 in Participants With Advanced Cancer
Completed
NCT01212107
Eli Lilly and Company
Advanced Cancer
Start: 2010-12-31
End: 2015-02-28
Updated: 2019-06-12
Phase 2
Activated Charcoal Use in Chronic Kidney Disease Patients
Recruiting
NCT06906874
Mansoura University
CKD 5D, Hemodialysis, CKD-MBD - Chronic Kidney Disease Mineral and Bone Disorder, End Stage Renal Disease (ESRD)
Start: 2025-08-31
End: 2025-11-30
Target: 40
Updated: 2025-08-08
Related Papers
A Phase 1 Study of LY2874455, an Oral Selective pan-FGFR Inhibitor, in Patients with Advanced Cancer.
2017-08-01
65 citations